Primary Care iSBIRT to Reduce Serious Teen Health Risks

NCT ID: NCT00891631

Last Updated: 2016-10-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

PHASE1/PHASE2

Study Classification

INTERVENTIONAL

Study Start Date

2009-09-30

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of the project is to develop and test an internet/intranet-based Screening, Brief Intervention, and Referral to Treatment (iSBIRT) system for adolescents that targets a broad range of serious health-risks and problem behaviors.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We have previously developed and tested a computerized substance use screening and feedback program for adolescents. We will expand this program to include other serious health risks, enhance the feedback and health risk information adolescents will receive on the computer, develop Technological Extenders to extend the effect of the intervention, develop a training video and protocol for providers, and pilot test the system among adolescents coming for non-urgent care at a variety of primary care sites.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Substance-related Disorders Depression High-risk Sex

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

iSBIRT

Participants will complete the iSBIRT system.

Group Type EXPERIMENTAL

iSBIRT

Intervention Type BEHAVIORAL

Participants will receive the internet/intranet based screening, brief intervention, and referral to treatment program.

iSBIRT/TE

Participants will receive the internet/intranet screening, brief intervention, and referral to treatment system and technological extenders

Group Type EXPERIMENTAL

iSBIRT/TE

Intervention Type BEHAVIORAL

Participants will receive the internet/intranet screening, brief intervention, and referral to treatment system along with technological extenders

TAU

Participants will receive Treatment as Usual from their primary care provider.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

iSBIRT

Participants will receive the internet/intranet based screening, brief intervention, and referral to treatment program.

Intervention Type BEHAVIORAL

iSBIRT/TE

Participants will receive the internet/intranet screening, brief intervention, and referral to treatment system along with technological extenders

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SBIRT SBIRT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 12-21 years old
* arriving for non-urgent care
* provide informed assent/consent

Exclusion Criteria

* less than 6th grade reading level
* unavailable for follow-up questionnaires
Minimum Eligible Age

12 Years

Maximum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boston Children's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

John R Knight, MD

Associate Professor of Pediatrics, Harvard Medical School; Senior Associate in Medicine; Associate in Psychiatry, Director, Center for Adolescent Substance Abuse Research, Boston Children's Hospital

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John R Knight, MD

Role: PRINCIPAL_INVESTIGATOR

Boston Children's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Children's Hospital Boston

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://www.ceasar.org

Web site of the Center for Adolescent Substance Abuse Research at Children's Hospital Boston

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

iSBIRT RFA-od-09-003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Building Healthy Children
NCT01888809 COMPLETED NA
Latino Teen Pregnancy Prevention K23
NCT06105905 ENROLLING_BY_INVITATION NA
IMPACCT for Kids' Care
NCT02298361 COMPLETED
Tennessee Youth Prepared for Success
NCT06001892 RECRUITING NA
Reducing Adolescent Pregnancy
NCT04120376 COMPLETED NA
Boston Birth Cohort Study
NCT03228875 RECRUITING
Healthy Adolescent Transitions (HAT)
NCT03194672 COMPLETED PHASE2